Edesa Biotech Inc (EDSA)
4.452
+0.01
(+0.21%)
USD |
NASDAQ |
May 01, 16:00
4.44
-0.01
(-0.28%)
After-Hours: 20:00
Edesa Biotech Price: 4.452 for May 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 01, 2024 | 4.390 | 4.452 | 4.390 | 4.452 | 589.00 |
| Apr 30, 2024 | 4.49 | 4.646 | 4.400 | 4.443 | 2513.00 |
| Apr 29, 2024 | 4.26 | 4.38 | 4.26 | 4.37 | 2858.00 |
| Apr 26, 2024 | 4.88 | 4.88 | 4.31 | 4.420 | 2308.00 |
| Apr 25, 2024 | 4.505 | 4.601 | 4.456 | 4.468 | 2359.00 |
| Apr 24, 2024 | 4.696 | 4.726 | 4.29 | 4.31 | 5087.00 |
| Apr 23, 2024 | 4.43 | 4.487 | 4.43 | 4.465 | 2343.00 |
| Apr 22, 2024 | 4.38 | 4.38 | 4.38 | 4.38 | 812.00 |
| Apr 19, 2024 | 4.35 | 4.48 | 4.250 | 4.45 | 2430.00 |
| Apr 18, 2024 | 4.444 | 4.444 | 4.293 | 4.36 | 1370.00 |
| Apr 17, 2024 | 4.36 | 4.40 | 4.36 | 4.40 | 568.00 |
| Apr 16, 2024 | 4.20 | 4.346 | 4.12 | 4.346 | 6150.00 |
| Apr 15, 2024 | 4.26 | 4.642 | 4.16 | 4.16 | 8124.00 |
| Apr 12, 2024 | 4.48 | 4.48 | 4.33 | 4.480 | 5805.00 |
| Apr 11, 2024 | 4.50 | 4.50 | 4.475 | 4.48 | 2853.00 |
| Apr 10, 2024 | 4.54 | 4.685 | 4.327 | 4.685 | 2547.00 |
| Apr 09, 2024 | 4.900 | 4.900 | 4.540 | 4.540 | 7644.00 |
| Apr 08, 2024 | 4.76 | 4.957 | 4.65 | 4.65 | 8866.00 |
| Apr 05, 2024 | 4.72 | 4.75 | 4.46 | 4.675 | 5987.00 |
| Apr 04, 2024 | 4.49 | 4.90 | 4.49 | 4.800 | 15453.00 |
| Apr 03, 2024 | 4.40 | 4.947 | 4.350 | 4.36 | 13771.00 |
| Apr 02, 2024 | 4.275 | 4.40 | 4.136 | 4.40 | 5028.00 |
| Apr 01, 2024 | 4.016 | 4.31 | 4.016 | 4.24 | 7254.00 |
| Mar 28, 2024 | 4.320 | 4.441 | 4.115 | 4.192 | 10227.00 |
| Mar 27, 2024 | 4.30 | 4.943 | 4.124 | 4.45 | 12413.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.55
Minimum
Nov 13 2023
83.44
Maximum
Sep 20 2021
24.81
Average
23.03
Median
Feb 05 2020
Price Benchmarks
| Acasti Pharma Inc | 2.850 |
| Aurinia Pharmaceuticals Inc | 5.20 |
| Lexaria Bioscience Corp | 3.475 |
| Xenon Pharmaceuticals Inc | 42.48 |
| ESSA Pharma Inc | 6.625 |
Price Related Metrics
| PS Ratio | 40.58 |
| Price to Book Value | 2.416 |
| Earnings Yield | -59.28% |
| Market Cap | 14.12M |